1513818 - Versartis, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - VSAR (1513818)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
92 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m
P8+3+8+3+75
S30+1-0+12+30

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Share Price

Shares Traded

Shares Owned

Own chg

Value Traded

1d ret

1w ret

1m ret

6m ret

2017-10-19
VSARWestberg PaulSVP, Chief Business OfficerS - Sale$2.55-1,326125,191-1%-$3,381
2017-10-19
VSARWard ShaneSVP, GCS - Sale$2.55-77692,574-1%-$1,979
2017-10-19
VSARHislop ColinChief Medical OfficerS - Sale$2.55-66723,833-3%-$1,701
2017-10-19
VSARBrumm Joshua TCOO, CFOS - Sale$2.55-1,326201,269-1%-$3,381
2017-10-06
VSARWoody Tracy MChief Commercial OfficerA - Grant$0.00+82,000127,000+182%+$0
2017-10-06
VSARWestberg PaulSVP, Chief Business OfficerA - Grant$0.00+59,000126,517+87%+$0
2017-10-06
VSARWard ShaneSVP, GCA - Grant$0.00+57,00093,350+157%+$0
2017-10-06
VSARStout Jay SSVP, Technical OperationsA - Grant$0.00+70,000116,000+152%+$0
2017-10-06
VSARShepard JayPres, CEOA - Grant$0.00+189,000393,744+92%+$0
2017-10-06
VSARGut RobertChief Medical OfficerA - Grant$0.00+88,000136,000+183%+$0
2017-10-06
VSARBrumm Joshua TCOO, CFOA - Grant$0.00+97,000202,595+92%+$0
M
2017-09-21
VSARPerceptive Advisors LLC10%S - Sale$3.29-2,130,0002,099,563-50%-$7,013,552
D
2017-09-05
VSARGut RobertChief Medical OfficerA - Grant$0.00+48,00048,000New+$0
2017-06-13
VSARWestberg PaulSVP, Chief Business OfficerS - Sale$16.05-71167,517-1%-$11,412
2017-06-13
VSARBrumm Joshua TCOO, CFOS - Sale$16.05-1,421105,595-1%-$22,807
D
2017-05-25
VSARAkkaraju SrinivasDirA - Grant$0.00+3,480586,384+1%+$0
D
2017-05-25
VSARGreer R ScottDirA - Grant$0.00+3,48033,180+12%+$0
D
2017-05-25
VSARJennings Edmon RDirA - Grant$0.00+3,48011,180+45%+$0
D
2017-05-25
VSARMalik ShahzadDirA - Grant$0.00+3,4801,634,2380%+$0
D
2017-05-25
VSARSun Anthony YDirA - Grant$0.00+3,48012,680+38%+$0
D
2017-05-25
VSARVarian JohnDirA - Grant$0.00+3,48011,080+46%+$0
D
2017-05-25
VSARDobmeier EricDirA - Grant$0.00+6,9606,960New+$0
2017-05-16
VSARBrumm Joshua TCOO, CFOS - Sale$17.40-1,263107,016-1%-$21,976
2017-04-19
VSARWestberg PaulSVP, Chief Business OfficerS - Sale$19.85-1,31668,228-2%-$26,1230+1
D
2017-04-03
VSARStout Jay SSVP, Technical OperationsA - Grant$0.00+45,00046,000>999%+$0-1-1-18
D
2017-04-04
VSARHislop ColinChief Medical OfficerM - OptEx$8.17+35,00024,500-333%+$285,950-1-1-18
D
2017-04-04
VSARHislop ColinChief Medical OfficerS - Sale+OE$21.20-35,00024,500-59%-$742,000-1-1-18
D
2017-03-22
VSARWoody Tracy MChief Commercial OfficerA - Grant$0.00+45,00045,000New+$00-4-13
2017-03-24
VSARAkkaraju SrinivasDirP - Purchase$12.25+571,429582,904>999%+$7,000,005+2-1-8
M
2017-03-16
VSARMalik ShahzadDirS - Sale$18.11-483,6701,630,758-23%-$8,758,575+8+8+7
M
2017-03-13
VSARMalik ShahzadDirS - Sale$19.09-166,3302,114,428-7%-$3,175,381-3+4+8
M
2017-03-14
VSARWard ShaneSVP, GCS - Sale$19.01-2,04136,350-5%-$38,795-3+4+8
AM
2017-02-10
VSARPerceptive Advisors LLC10%P - Purchase$15.30+94,0164,229,563+2%+$1,438,7060+8+8
D
2017-02-27
VSARWestberg PaulSVP, Chief Business OfficerM - OptEx$1.98+12,50069,544+22%+$24,7170-8-1
D
2017-02-27
VSARWestberg PaulSVP, Chief Business OfficerS - Sale+OE$22.50-12,50069,544-15%-$281,2500-8-1
D
2017-02-27
VSARShepard JayPres, CEOM - OptEx$2.53+5,166213,858+2%+$13,0700-8-1
D
2017-02-27
VSARShepard JayPres, CEOS - Sale+OE$24.00-5,166213,858-2%-$123,9840-8-1
D
2017-02-24
VSARBrumm Joshua TCOO, CFOM - OptEx$2.53+30,000105,779+40%+$75,9000-8-1
D
2017-02-24
VSARBrumm Joshua TCOO, CFOS - Sale+OE$20.94-30,000105,779-22%-$628,0630-8-1
DM
2017-02-21
VSARWestberg PaulSVP, Chief Business OfficerM - OptEx$1.61+25,00069,544+56%+$40,250+6+4-3
DM
2017-02-21
VSARWestberg PaulSVP, Chief Business OfficerS - Sale+OE$18.75-25,00069,544-26%-$468,750+6+4-3
DM
2017-02-21
VSARShepard JayPres, CEOM - OptEx$2.53+16,000213,858+8%+$40,480+6+4-3
DM
2017-02-21
VSARShepard JayPres, CEOS - Sale+OE$19.25-16,000213,858-7%-$308,000+6+4-3
M
2017-02-10
VSARPerceptive Advisors LLC10%P - Purchase$15.30+94,0164,228,563+2%+$1,438,706-1+21+22
M
2017-02-08
VSARPerceptive Advisors LLC10%P - Purchase$13.72+145,8234,134,547+4%+$2,001,247+4+9+34
2017-02-03
VSARShepard JayPres, CEOS - Sale$13.69-6,719213,858-3%-$91,983-4+9+45
DM
2017-01-31
VSARShepard JayPres, CEOM - OptEx$2.53+21,404220,577+11%+$54,152+4+1+56
DM
2017-01-31
VSARShepard JayPres, CEOS - Sale+OE$13.77-24,211220,577-10%-$333,326+4+1+56
D
2017-01-27
VSARBrumm Joshua TCOO, CFOA - Grant$0.00+43,900105,779+71%+$0-2-4+58
D
2017-01-30
VSARBrumm Joshua TCOO, CFOS - Sale+OE$13.85-2,945105,779-3%-$40,794-2-4+58
D
2017-01-27
VSARShepard JayPres, CEOA - Grant$0.00+74,700223,384+50%+$0-2-4+58
D
2017-01-30
VSARShepard JayPres, CEOM - OptEx$2.53+10,596223,384+5%+$26,808-2-4+58
D
2017-01-30
VSARShepard JayPres, CEOS - Sale+OE$13.52-17,270223,384-7%-$233,468-2-4+58
D
2017-01-27
VSARHislop ColinChief Medical OfficerA - Grant$0.00+19,50024,500+390%+$0-2-4+58
D
2017-01-27
VSARWard ShaneSVP, GCA - Grant$0.00+20,60038,391+116%+$0-2-4+58
D
2017-01-30
VSARWard ShaneSVP, GCS - Sale+OE$13.85-1,47438,391-4%-$20,418-2-4+58
D
2017-01-27
VSARWestberg PaulSVP, Chief Business OfficerA - Grant$0.00+26,86069,544+63%+$0-2-4+58
D
2017-01-30
VSARWestberg PaulSVP, Chief Business OfficerS - Sale+OE$13.85-1,91669,544-3%-$26,540-2-4+58
DM
2017-01-09
VSARWestberg PaulSVP, Corporate DevelopmentM - OptEx$1.43+32,50044,600+269%+$46,580-1-2-7
DM
2017-01-09
VSARWestberg PaulSVP, Corporate DevelopmentS - Sale+OE$15.67-32,50044,600-42%-$509,225-1-2-7
A
2016-12-30
VSARPerceptive Advisors LLC10%P - Purchase$14.66+71,0633,989,724+2%+$1,041,641+7+5-9
2016-12-30
VSARPerceptive Advisors LLC10%P - Purchase$14.66+94,7504,013,411+2%+$1,388,846+7+5-9
2016-12-29
VSARPerceptive Advisors LLC10%P - Purchase$14.37+47,3753,918,661+1%+$680,589+3+12-1
2016-12-27
VSARWestberg PaulSVP, Corporate DevelopmentS - Sale$15.85-36144,600-1%-$5,722+3+9-10
2016-12-27
VSARBrumm Joshua TCFOS - Sale$15.85-99064,824-2%-$15,692+3+9-10
D
2016-12-16
VSARWestberg PaulSVP, Corporate DevelopmentM - OptEx$1.26+5,00044,961+13%+$6,325+6+7+1
D
2016-12-16
VSARWestberg PaulSVP, Corporate DevelopmentS - Sale+OE$15.00-5,00044,961-10%-$75,000+6+7+1
2016-12-08
VSARJennings Edmon RDirS - Sale$12.96-1,5007,700-16%-$19,433-2-4+20
2016-12-07
VSARBrumm Joshua TCFOS - Sale$13.25-3,02165,814-4%-$40,028-2-4+20
2016-10-11
VSARBrumm Joshua TCFOA - Grant$0.00+10,00068,835+17%+$0-200+76
2016-10-11
VSARHislop ColinChief Medical OfficerA - Grant$0.00+5,0005,000New+$0-200+76
2016-10-11
VSARWard ShaneSVP, Legal, ComplianceA - Grant$0.00+5,00019,265+35%+$0-200+76
2016-10-11
VSARWestberg PaulSVP, Corporate DevelopmentA - Grant$0.00+10,00044,961+29%+$0-200+76
2016-10-03
VSARAkkaraju SrinivasDirP - Purchase$12.25+571,429582,904>999%+$7,000,0050+1-12+75
2016-08-25
VSARVarian JohnDirS - Sale$12.97-1,6007,600-17%-$20,755+3+40+82
2016-08-22
VSARShepard JayPres, CEOS - Sale$12.88-5,442155,358-3%-$70,0930+4+3+64
D
2016-06-14
VSARAkkaraju SrinivasDirA - Grant$0.00+6,90011,475+151%+$0+4-4-3+22
2016-06-15
VSARBrumm Joshua TCFOS - Sale$10.63-1,44858,835-2%-$15,3920+60+17
2016-06-15
VSARWestberg PaulSVP, Business DevelopmentS - Sale$10.63-72534,961-2%-$7,7070+60+17
2016-05-20
VSARBrumm Joshua TCFOS - Sale$7.87-1,26560,283-2%-$9,956+8+8+36+57
D
2016-05-18
VSARMalik ShahzadDir, 10%A - Grant$0.00+4,6252,280,7580%+$0+8+8+36+57
D
2016-05-18
VSARGreer R ScottDirA - Grant$0.00+4,62529,700+18%+$0+8+8+36+57
D
2016-05-18
VSARJennings Edmon RDirA - Grant$0.00+4,6259,200+101%+$0+8+8+36+57
D
2016-05-18
VSARSun Anthony YDirA - Grant$0.00+4,6259,200+101%+$0+8+8+36+57
D
2016-05-18
VSARVarian JohnDirA - Grant$0.00+4,6259,200+101%+$0+8+8+36+57
2016-04-21
VSARWestberg PaulSVP, Business DevelopmentS - Sale$9.68-1,43035,686-4%-$13,842-3-10-13+20
D
2016-01-28
VSARBrumm Joshua TCFOA - Grant$0.00+26,00061,548+73%+$0-11-18-37+1
D
2016-01-28
VSARWestberg PaulSVP, Business DevelopmentA - Grant$0.00+16,90037,116+84%+$0-11-18-37+1
D
2016-01-28
VSARShepard JayPres, CEOA - Grant$0.00+64,800160,800+68%+$0-11-18-37+1
D
2016-01-28
VSARWard ShaneSVP, Legal, ComplianceA - Grant$0.00+13,00014,265>999%+$0-11-18-37+1
2015-12-30
VSARWestberg PaulSVP, Business DevelopmentS - Sale$12.44-36220,216-2%-$4,5020-16-15-9
2015-12-30
VSARBrumm Joshua TCFOS - Sale$12.44-99035,548-3%-$12,3120-16-15-9

Real-time CSV? Options? Alerts? Contact us!
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top